Clinical trial
Probiotics for Reduction of Colonisation With Clostridium Difficile in Antibiotic Treated Intensive Care Patients
NCT01687543 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Probiotics for Reduction of Colonisation With Clostridium Difficile in Antibiotic Treated Intensive Care Patients
- Lead sponsor
- Region Skane
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2012
- Completion date
- October 1, 2017
- Enrollment
- 25 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
clostridium difficile colonisation, impact of enteral probiotics on certain lab parameters